Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.94
-0.10 (-1.11%)
At close: Sep 26, 2025, 4:00 PM EDT
8.95
+0.01 (0.11%)
After-hours: Sep 26, 2025, 4:10 PM EDT
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$139,254
Profits / Employee
$4,904,159
Market Cap
8.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADXN News
- 1 day ago - Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025 - GlobeNewsWire
- 4 days ago - Addex Appoints Bank of New York Mellon as Depositary Bank - GlobeNewsWire
- 3 months ago - Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs - GlobeNewsWire
- 3 months ago - Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders - GlobeNewsWire
- 3 months ago - Addex Shareholders Approve All Resolutions at Annual General Meeting - GlobeNewsWire
- 3 months ago - Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewsWire
- 4 months ago - Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models - GlobeNewsWire